會員登入
註冊
NBI與AMEX生技指數各跌2.13%、2.32%，NYSE藥業指數漲1.15%。
| 2021年12月－美股7日漲跌幅排名(1223-1231) | |||||
| 個股代碼 | 名稱 | 本周收價(美元) | 上周收價(美元) | 漲跌幅 | 備註 |
| IBB | iShares Biotechnology ETF | 152.62 | 154.69 | -1.34% | |
| #NBI | NASDAQ生物科技指數 | 4728.94 | 4831.64 | -2.13% | |
| #BTK | AMEX生物科技指數 | 5518.5 | 5649.5 | -2.32% | |
| 個股代碼 | 名稱 | 本周收價(美元) | 上周收價(美元) | 漲跌幅 | 分類 |
| BIIB | Biogen | 239.92 | 235.41 | 1.92% | 生技 |
| ABBV | AbbVie | 135.4 | 133.09 | 1.74% | 製藥 |
| JNJ | Johnson & Johnson | 171.07 | 168.25 | 1.68% | 製藥 |
| CI | Cigna | 229.63 | 225.89 | 1.66% | 醫療保健 |
| MRK | Merck | 76.64 | 75.73 | 1.20% | 製藥：PD-1 |
| LLY | Eli Lilly and | 276.22 | 273.1 | 1.14% | 製藥 |
| ABT | Abbott Laboratories | 140.74 | 139.16 | 1.14% | 製藥 |
| AZN | AstraZeneca PLC | 58.25 | 57.64 | 1.06% | 製藥 |
| REGN | Regeneron Pharmaceuticals | 631.52 | 625.38 | 0.98% | 製藥 |
| NVS | Novartis AG | 87.47 | 86.66 | 0.93% | 製藥 |
| GSK | GlaxoSmithKline PLC | 44.1 | 43.76 | 0.78% | 製藥 |
| PFE | Pfizer | 59.05 | 58.71 | 0.58% | 製藥 |
| SNY | Sanofi | 50.1 | 49.83 | 0.54% | 製藥 |
| AMGN | Amgen | 224.97 | 223.79 | 0.53% | 生技 |
| BMY | Bristol-Myers Squibb | 62.35 | 62.05 | 0.48% | 製藥：PD-1 |
| GILD | Gilead Sciences | 72.61 | 72.48 | 0.18% | 生技 |
| MACK | Merrimack Pharmaceuticals | 3.91 | 3.915 | -0.13% | 台灣授權 |
| ILMN | Illumina | 380.44 | 382.29 | -0.48% | 生技：醫材 |
| CLLS | Cellectis S.A. | 8.12 | 8.55 | -5.03% | 生技：CART |
| TEVA | Teva Pharmaceutical Industries | 8.01 | 8.46 | -5.32% | 製藥 |
| NTLA | Intellia Therapeutics | 118.24 | 126.81 | -6.76% | 基因編輯 |
| CRSP | CRISPR Therapeutics AG | 75.78 | 82.15 | -7.75% | 基因編輯 |
| ASLN | ASLAN Pharmaceuticals | 1.12 | 1.24 | -9.68% | 製藥(臺美雙掛牌) |
| AKBA | Akebia Therapeutics | 2.26 | 2.53 | -10.67% | 製藥(併KERX) |
| EDIT | Editas Medicine | 26.55 | 29.94 | -11.32% | 基因編輯 |
| BLUE | bluebird bio | 9.99 | 11.4 | -12.37% | 生技：CART |
| CLVS | Clovis Oncology | 2.71 | 3.17 | -14.51% | 製藥：PARP |
